Boston (Massachusetts) & Manchester (New Hampshire) United States of America
Are you working in the multidisciplinary field of Regenerative Medicine? Whether you're a researcher, entrepreneur, engineer, or clinician, and are interested in connecting with USA experts to exchange knowledge and explore collaboration opportunities, we invite you to join the innovation mission to Boston and Manchester, USA, from April 6 to 11, 2025.
Regenerative medicine is rapidly advancing both in the Netherlands and the United States, particularly in Boston, Massachusetts, and Manchester, New Hampshire.
Why Boston and Manchester?
Boston, Massachusetts is a well-known global powerhouse in the Life Sciences and Health sector. From research and development to entrepreneurship and commercialization, Boston paves the way in biotechnology, due in large part to its supportive ecosystem of government, corporates, universities, risk capital and entrepreneurs. Additionally, the partnership (both MOU and Program of Cooperation on LSH) between Massachusetts and the Netherlands is a unique one with no equivalent formalized agreement signed between the government of Massachusetts and any other country. The core of this partnership is to improve patients’ lives and remains relevant and successful due to the dedication of both parties to this transatlantic collaboration.
The ReGen Valley Tech Hub in Manchester, New Hampshire, aims to make New Hampshire a global leader in bio fabrication to produce cost-effective regenerative therapies that address chronic disease and organ failure. A recent EDA Build Back Better Regional Challenge federal award of $44 million will further advance the development of the ReGen Valley Tech Hub by establishing the region as the global epicenter for the production and distribution of regenerative tissues and organs.
What to Expect from the Mission
This mission will bring together experts from both the Dutch and U.S. ecosystems to connect, explore research and development opportunities, and collaborate on advancing regenerative medicine solutions. Together, we aim to build a new industrial sector focused on improving patient outcomes.
Who Should Participate?
This mission is designed for entrepreneurs, researchers, engineers, clinicians, ethicists, business developers, and anyone affiliated with a knowledge institution, academic medical center, technology company, or patient organization. If you are actively involved in the fields of regenerative medicine and life sciences, this innovation mission could be of interest to you.
Concept program
The visit program offers a unique opportunity to be at the forefront of American developments in regenerative medicine. With a focus on the dynamic ecosystems in Boston (MA) and Manchester (NH), the mission will feature multiple networking opportunities which important stakeholders from both regions. Think of company visits, panel discussions and potentially attending a summit. This will be an invaluable opportunity to explore potential collaborations and expand your professional network.
The mission program is organized by RVO and the Netherlands Innovation Network in Boston, in partnership with RegMedXB and Health~Holland.
The program is under development. We will tailor the final program to meet the interests of participants as much as possible. Next week, more details can be found on our website.
Costs
The cost of participating in the innovation mission is €250 excl. VAT per person. This includes:
• participation in the collective program
• transfers to and from program components
• lunch and dinners if mentioned in the program
Participation does not include:
• travel and accommodation costs (intercontinental and domestic flights and hotels)
• all individual costs, such as lunches and dinners outside the program
How to Participate
If you are interested in joining this innovation mission, please complete the registration form by January 31, 2025. Final participation will depend on the number of available spots and how well your organization aligns with the mission’s goals and objectives.
Want to learn more?
If you have any questions or need further information, please contact:
Niels van Leeuwen
Senior Advisor International R&D Life Sciences & Health
E: niels.vanleeuwen@rvo.nl
M: +31 (0) 6 5256 3310